Clinical Trial Update: Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating an antibiotic regimen targeting Mycobacterium avium paratuberculosis for Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Crohn's Disease | Phase 4 | Status: WITHDRAWN